Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article

Objective Several tools have been developed to evaluate the extent to which the findings from a network meta-analysis would be valid; however, applying these tools is a time-consuming task and often requires specific expertise. Clinicians have little time for critical appraisal, and they need to understand the key elements that help them select network meta-analyses that deserve further attention, optimising time and resources. This paper is aimed at providing a practical framework to assess the methodological robustness and reliability of results from network meta-analysis. Methods As a working example, we selected a network meta-analysis about drug treatments for generalised anxiety disorder, which was published in 2011 in the British Medical Journal. The same network meta-analysis was previously used to illustrate the potential of this methodology in a methodological paper published in JAMA. Results We reanalysed the 27 studies included in this network following the methods reported in the original article and compared our findings with the published results. We showed how different methodological approaches and the presentation of results can affect conclusions from network meta-analysis. We divided our results into three sections, according to the specific issues that should always be addressed in network meta-analysis: (1) understanding the evidence base, (2) checking the statistical analysis and (3) checking the reporting of findings. Conclusions The validity of the results from network meta-analysis depends on the plausibility of the transitivity assumption. The risk of bias introduced by limitations of individual studies must be considered first and judgement should be used to infer about the plausibility of transitivity. Inconsistency exists when treatment effects from direct and indirect evidence are in disagreement. Unlike transitivity, inconsistency can be always evaluated statistically, and it should be specifically investigated and reported in the published paper. Network meta-analysis allows researchers to list treatments in preferential order; however, in this paper we demonstrated that rankings could be misleading if based on the probability of being the best. Clinicians should always be interested in the effect sizes rather than the naive rankings.

[1]  Dimitris Mavridis,et al.  A primer on network meta-analysis with emphasis on mental health , 2015, Evidence-Based Mental Health.

[2]  Dimitris Mavridis,et al.  A hands-on practical tutorial on performing meta-analysis with Stata , 2014, Evidence-Based Mental Health.

[3]  L. Trinquart,et al.  Association between analytic strategy and estimates of treatment outcomes in meta-analyses. , 2014, JAMA.

[4]  R. Golub,et al.  Meta-analysis as evidence: building a better pyramid. , 2014, JAMA.

[5]  Anna Chaimani,et al.  Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.

[6]  J. Geddes,et al.  Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism , 2014, BMC Medicine.

[7]  Deborah M Caldwell,et al.  Novel presentational approaches were developed for reporting network meta-analysis. , 2014, Journal of clinical epidemiology.

[8]  P. Gorman,et al.  Clinical questions raised by clinicians at the point of care: a systematic review. , 2014, JAMA internal medicine.

[9]  Kristian Thorlund,et al.  The Quality of Reporting Methods and Results in Network Meta-Analyses: An Overview of Reviews and Suggestions for Improvement , 2014, PloS one.

[10]  Christopher H. Schmid,et al.  Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks , 2014, PloS one.

[11]  Panagiota Spyridonos,et al.  Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.

[12]  Kristian Thorlund,et al.  The effects of excluding treatments from network meta-analyses: survey , 2013, BMJ : British Medical Journal.

[13]  Andrea Cipriani,et al.  Conceptual and Technical Challenges in Network Meta-analysis , 2013, Annals of Internal Medicine.

[14]  Huseyin Naci,et al.  Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers , 2013, BMC Medicine.

[15]  Kristian Thorlund,et al.  Demystifying trial networks and network meta-analysis , 2013, BMJ.

[16]  Kristian Thorlund,et al.  How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.

[17]  AE Ades,et al.  Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡ , 2012, Research synthesis methods.

[18]  David Taylor,et al.  Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis , 2011, BMJ : British Medical Journal.

[19]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[20]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[21]  N. Welton,et al.  Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation , 2009, Statistics in medicine.

[22]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[23]  T. Lumley Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.

[24]  P. Silverstone,et al.  Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. , 2001, The Journal of clinical psychiatry.

[25]  A. Ravindran,et al.  Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. , 1999, The Journal of clinical psychiatry.

[26]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[27]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. , 2013 .